Regeneron Pharmaceuticals Inc (OQ:REGN)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for REGN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Oct 1/18 Sep 28/18 Goldstein Joseph L Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -709  
Oct 1/18 Sep 28/18 Goldstein Joseph L Direct Ownership Common Stock S - Open market or private sale -709 $410.00
Oct 1/18 Sep 28/18 Goldstein Joseph L Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 709 $273.67
Oct 1/18 Sep 27/18 Goldstein Joseph L Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,000  
Oct 1/18 Sep 27/18 Goldstein Joseph L Direct Ownership Common Stock S - Open market or private sale -2,000 $400.00
Oct 1/18 Sep 27/18 Goldstein Joseph L Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,000 $273.67
Sep 28/18 Sep 27/18 Brown Michael S Direct Ownership Common Stock S - Open market or private sale -260 $395.42
Sep 28/18 Sep 27/18 Brown Michael S Direct Ownership Common Stock S - Open market or private sale -40 $394.43
Sep 28/18 Sep 27/18 Brown Michael S Direct Ownership Common Stock S - Open market or private sale -300 $393.49
Sep 28/18 Sep 27/18 Brown Michael S Direct Ownership Common Stock S - Open market or private sale -410 $392.37
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for REGN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Oct 1/18 Sep 28/18 Goldstein Joseph L Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -709  
Oct 1/18 Sep 27/18 Goldstein Joseph L Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,000  
Oct 1/18 Sep 28/18 Goldstein Joseph L Direct Ownership Common Stock S - Open market or private sale -709 $410.00
Oct 1/18 Sep 28/18 Goldstein Joseph L Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 709 $273.67
Oct 1/18 Sep 27/18 Goldstein Joseph L Direct Ownership Common Stock S - Open market or private sale -2,000 $400.00
Oct 1/18 Sep 27/18 Goldstein Joseph L Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,000 $273.67
Sep 28/18 Sep 27/18 Brown Michael S Direct Ownership Common Stock S - Open market or private sale -260 $395.42
Sep 28/18 Sep 27/18 Brown Michael S Direct Ownership Common Stock S - Open market or private sale -40 $394.43
Sep 28/18 Sep 27/18 Brown Michael S Direct Ownership Common Stock S - Open market or private sale -300 $393.49
Sep 28/18 Sep 27/18 Brown Michael S Direct Ownership Common Stock S - Open market or private sale -410 $392.37
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $REGN

StockTwits